Crossmark

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

Crossref DOI link: https://doi.org/10.1016/S1470-2045(16)30383-7

Published Print: 2016-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wallington, Michael

Saxon, Emma B

Bomb, Martine

Smittenaar, Rebecca

Wickenden, Matthew

McPhail, Sean

Rashbass, Jem

Chao, David

Dewar, John

Talbot, Denis

Peake, Michael

Perren, Timothy

Wilson, Charles

Dodwell, David
License Information

Text and Data Mining valid from 2016-09-01

Text and Data Mining valid from 2016-09-01

Version of Record valid from 2016-08-30
More Information

This article is maintained by: Elsevier

Article Title: 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

Journal Title: The Lancet Oncology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1470-2045(16)30383-7

CrossRef DOI link to the associated document: https://doi.org/10.1016/S1470-2045(16)30405-3

Content Type: article

Copyright: © 2016 The Authors. Published by Elsevier Ltd.